Nutrition counseling recommended to reduce malnutrition in oncology patients
the ONA take:
The referral of oncology patients for nutrition counseling is recommended given the strong evidence of its beneficial effects on the prevention and reduction of malnutrition, a new study published online ahead of print in the journal Supportive Care in Cancer has shown.
Because malnutrition is a very common problem among patients with cancer and is associated with various negative consequences including poorer prognosis, quality of life, and survival, researchers sought to review the effectiveness of different nutrition intervention approaches on nutrition status in oncology patients.
Researchers assessed the effects of nutrition counseling, oral nutrition supplements (ONS), and tube feeding (TF) on nutrition status by analyzing 11 randomized controlled trials that included a total of 1,077 patients.
Results showed that nutrition counseling with or without oral nutrition supplements was associated with consistent improvements in several nutrition status outcomes. On the other hand, oral nutrition supplements and tube feeding were associated with inconsistent improvements in limited aspects of nutrition status outcomes.
“Other forms of nutrition support including ONS and TF may then be included if deemed suitable and necessary for the individual,” the authors conclude.
Nutrition counseling is recommended given the strong evidence of its beneficial effects on the prevention and reduction of malnutrition.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|